On The Pen GLP-1 News
Retatrutide Before FDA Approval? Lilly Just Changed the Conversation
June 9, 2026·20 min
Episode Description from the Publisher
Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from On The Pen GLP-1 News
What Comes After Zepbound? The Biggest ADA 2026 Obesity Drug Breakthroughs
June 16, 2026·1h 15m
Retatrutide Just Reached Bariatric Surgery Results
June 11, 2026·48 min
Eli Lilly Isn’t Telling Us About Their Future Obesity Drugs
June 2, 2026·20 min
Retatrutide, Multi Agonist Obesity Drugs, and the PBM Access War
May 26, 2026·30 min
Get summaries like this every morning.
Free AI-powered recaps of On The Pen GLP-1 News and your other favorite podcasts, delivered to your inbox.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.